HIGHLIGHTS
- who: SR and colleagues from the Soochow University, China have published the research: Rev-erb agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway, in the Journal: (JOURNAL)
- what: Given the background above, in the present study, the authors aimed to elucidate whether Rev-erbu03b1 activation by SR9009 protects against neurological deficits and brain damage in a transient focal cerebral ischemic mouse model and whether the underlying mechanism Frontiers in Pharmacology The authors found the neuroprotective effects of SR9009 in a stroke model and provided a novel mechanism.
- how: Together . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.